Rebif

In the US, Rebif (interferon beta-1a systemic) is a member of the drug class interferons and is used to treat Multiple Sclerosis and Neuritis.

US matches:

• Rebif

UK matches:

• Rebif solution for injection in cartridges (SPC)
• Rebif Solution for Injection in Pre-filled Pens (SPC)
• Rebif solution for injection in pre-filled syringes (SPC)

Ingredient matches for Rebif

Interferon beta

Interferon beta Interferon beta-1a (a derivative of Interferon beta) is reported as an ingredient of Rebif in the following countries:

• Argentina


• Australia


• Austria


• Belgium


• Canada


• China


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Finland


• France


• Germany


• Greece


• Hungary


• Iceland


• India


• Ireland


• Israel


• Italy


• Luxembourg


• Netherlands


• Norway


• Oman


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• South Africa


• Spain


• Sweden


• Switzerland


• Taiwan


• Tunisia


• Turkey


• United Kingdom


• United States


• Venezuela

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.